Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

Practice guidelines for pulmonary artery catheterization: an updated report by the American Society of Anesthesiologists Task Force on Pulmonary Artery Catheterization.

BIBLIOGRAPHIC SOURCE(S)

GUIDELINE STATUS

This is the current release of the guideline.

BRIEF SUMMARY CONTENT

 
RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

Recommendations

The votes by the Task Force (see tables 6 and 7 of the original guideline document) demonstrated that the appropriateness of routine pulmonary artery (PA) catheterization depends on the combination of risks associated with the (a) patient, (b) surgery, and (c) practice setting (the latter referring to the risks from PA catheterization introduced by practice conditions and staff circumstances). The votes are depicted graphically in figure 3 of the original guideline document. With some exceptions, routine catheterization is generally inappropriate for low- or moderate-risk patients. The three variables are defined in greater detail below.

Patient

Patients at increased risk for hemodynamic disturbances are those with clinical evidence of significant cardiovascular disease, pulmonary dysfunction, hypoxia, renal insufficiency, or other conditions associated with hemodynamic instability (e.g., advanced age, endocrine disorders, sepsis, trauma, burns). Patients at low risk include those with American Society of Anesthesiologists (ASA) physical status of 1 or 2 or those with hemodynamic disturbances unlikely to cause organ dysfunction. Those at moderate risk are in category ASA 3 or have hemodynamic disturbances that occasionally cause organ dysfunction. Those at high risk are in category ASA 4 or 5 and have hemodynamic disturbances with a great chance of causing organ dysfunction or death. The assessment of risk should be based on a thorough analysis of the medical history and physical examination findings, rather than on exclusive consideration of specific laboratory results or other quantitative criteria.

Procedure

Surgical procedures associated with an increased risk of complications from hemodynamic changes, including damage to the heart, vascular tree, kidneys, liver, lungs, or brain, may increase the chance of benefiting from PA catheterization. This report does not provide a list of indicated procedures and disease states for catheterization because the Task Force believes that catheterization decisions should be based on the hemodynamic risk characteristics of the individual case rather than on the type of procedure. The Task Force defines low-risk procedures as those carrying a small probability of fluid changes or hemodynamic disturbances and having low perioperative morbidity or mortality. Moderate-risk procedures have a moderate chance of fluid changes, hemodynamic disturbances, or infection that could cause morbidity or mortality. High-risk procedures have a predictably large chance of fluid changes or hemodynamic disturbances or other factors with high risk of morbidity and mortality.

Patients undergoing procedures that usually lack hemodynamic complications may need PA catheterization if circumstances pose a special risk. The clinician should therefore assess hemodynamic risks based on the case at hand and not on generic criteria.

Practice Setting

The setting for the procedure may increase the risk of complications from hemodynamic changes. Factors that should be considered in assessing perioperative risk include catheter use skills and technical support. Factors affecting postoperative risk include the level of training and experience of nursing staff in the recovery room and intensive care unit (ICU), technical support for ancillary services, and the availability of specialists and equipment to manage potential complications detected by the PA catheter.

CLINICAL ALGORITHM(S)

None provided

EVIDENCE SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

The recommendations are based on expert opinion, informed by scientific evidence. Clinical trials, controlled observational studies, uncontrolled case series reports, and individual case reports were considered.

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

ADAPTATION

Not applicable: The guideline was not adapted from another source.

DATE RELEASED

2003 Oct

GUIDELINE DEVELOPER(S)

American Society of Anesthesiologists - Medical Specialty Society

SOURCE(S) OF FUNDING

American Society of Anesthesiologists

GUIDELINE COMMITTEE

Task Force on Pulmonary Artery Catheterization

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Task Force Members: Michael F. Roizen, MD (Chair), Department of Anesthesiology, SUNY Upstate, Syracuse, New York, and Department of Anesthesia and Critical Care, University of Chicago, Chicago, Illinois; David L. Berger, MD (Private Practice), Piedmont, California; Ronald A. Gabel, MD, Department of Anesthesiology, University of Rochester, Rochester, New York; John Gerson, MD (Private Practice), Syracuse, New York; Jonathan B. Mark, MD, Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina; Robert I. Parks, Jr., MD (Private Practice), Dallas, Texas; David A. Paulus, MD, Department of Anesthesiology, University of Florida, Gainesville, Florida; John S. Smith, MD (Private Practice), Las Vegas, Nevada; and Steven H. Woolf, MD, M.P.H. (Methodology Consultant), Department of Family Practice, Virginia Commonwealth University, Fairfax, Virginia

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

Not stated

GUIDELINE STATUS

This is the current release of the guideline.

GUIDELINE AVAILABILITY

Electronic copies: Available from the American Society for Anesthesiologists Web site.

Print copies: Available from the American Society for Anesthesiologists, 520 North Northwest Highway, Park Ridge, IL 60068-2573.

AVAILABILITY OF COMPANION DOCUMENTS

None available

PATIENT RESOURCES

None available

NGC STATUS

This NGC summary was completed by ECRI on July 13, 2005. The information was verified by the guideline developer on July 20, 2005.

COPYRIGHT STATEMENT

This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions.

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo